Insilico Medicine
Curated by SignalAI driven age prediction tool
Overview
Insilico Medicine is using artificial intelligence to develop biomarkers of human aging and health status. The company's product, called Aging.AI claims to be a deep-learned predictor of age that has been trained on hundreds of thousands of anonymized human blood tests. One can provide blood test results along with weight, height, and smoking status for the system to calculate his or her age. The company intends to leverage the system to test effects of lifestyle interventions such as diet or exercise on the status of health and age-related markers. The company collaborates with the Biogerontology Research Foundation to develop its biomarker programs.
Key facts
- Founded
- 2014
- Headquarters
- Berlin, Germany
- Stage
- Sign up to view
- Industry
- Life Sciences Technology
Contact
- Sign up to view